推的工具化合物用于黑色皮质素受体 (MCR) G蛋白结合受体 (GPCRs)
Nicholas A Weirath1, Carrie Haskell-Luevano1
1Department of Medicinal Chemistry & Institute for Translational Neuroscience, University of Minnesota, Minneapolis, Minnesota 55455, United States.
ACS pharmacology & translational science
|September 19, 2024
概括
合成的黑色素皮质蛋白受体配体,如黑色素二,是理解受体功能和开发新药的关键工具. 这些化合物有助于结构研究和用于各种生理过程的药物发现.
科学领域:
- 生物化学和药理学 生物化学和药理学
- G蛋白结合受体 (GPCR) 研究研究
- 药物的发现和开发.
背景情况:
- 黑色皮质蛋白受体 (MCRs) 是A类GPCRs,参与着色素,能量稳态和类固醇生成.
- 到2020年,MCRs的结构数据有限,需要依赖突变发生和结构-活性关系 (SAR) 研究.
- 合成的MCR配体,如NDP-MSH和黑色素II (MTII),已成为重要的研究工具.
研究的目的:
- 审查关键合成黑色素皮质蛋白受体连接体的历史和重要性.
- 讨论这些工具化合物的实用性,以促进MCR研究.
- 突出它们在了解MCR生理学和药物开发中的作用.
主要方法:
- 关于合成黑色素皮质蛋白受体连接体的历史和当前文献的综述.
- 分析这些配体在各种研究方法中的应用.
- 讨论它们在结构生物学和药物发现中的作用.
主要成果:
- 合成配体如NDP-MSH,MTII和SHU9119对于MCR研究是不可或缺的.
- 这些化合物有助于结构研究 (X射线结晶学,冷EM) 和验证细胞系.
- 它们作为高通量选和行动研究机制的基本参考.
结论:
- 合成的黑色素皮质蛋白受体配体对于我们对MCR生理学的理解至关重要.
- 这些工具化合物在开发针对MCRs的新疗法方面发挥了重要作用.
- 它们的持续使用有望增强药物发现,并深入了解受体功能.
更多相关视频
相关概念视频
Transducer Mechanism: G Protein–Coupled Receptors
1.9K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
1.9K
G Protein-coupled Receptors
11.5K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
11.5K
G-protein Coupled Receptors
117.0K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
117.0K
GPCRs Regulate Adenylyl Cylase Activity
5.3K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.3K
Activation and Inactivation of G Proteins
6.8K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
6.8K
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K


